Van Bergen NJ et al. NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses. Brain 142, 50-58, doi:10.1093/brain/awy310 (2019). PMID: 30576410.
Van Bergen NJ et al. Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency. J Inherit Metab Dis 45, 1028-1038, doi:10.1002/jimd.12541 (2022). PMID: 35866541.
Van Bergen NJ et al. Severe NAD(P)HX Dehydratase (NAXD) Neurometabolic Syndrome May Present in Adulthood after Mild Head Trauma. Int J Mol Sci 24, doi:10.3390/ijms24043582 (2023). PMID: 36834994.
Zhou J et al. NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses. Brain, doi:10.1093/brain/awz375 (2019). PMID: 30576410.
Manor J et al. Niacin therapy improves clinical outcome with normalization of metabolic abnormalities in a patient with NAXD deficiency. Brain (2021). PMID: 35231119.
Al-Amrani et al. Transient response to high-dose niacin therapy in a patient with NAXE deficiency. JIMD Rep (2024), 65, 212-225. PMID: 38974613.